Next Article in Journal
Proteome Profiling of Rabies-Infected and Uninfected Dog Brain Tissues, Cerebrospinal Fluids and Serum Samples
Previous Article in Journal
Insights into Missense SNPs on Amyloidogenic Proteins
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Proteomes
Volume 13
Issue 4
10.3390/proteomes13040065
proteomes-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Proteomic Profiling of Non-Muscle Invasive Bladder Cancer Reveals Stage-Specific Molecular Signatures and Prognostic Biomarkers

by
Lorenza Vantaggiato
1,
Marco Frisenda
2,
Enxhi Shaba
1,
Chiara Splendore
2,
Beatrice Sciarra
3,
Luca Bini
1,
Alessandro Sciarra
2 and
Claudia Landi
1,*
1
Functional Proteomics Laboratory, Department of Life Sciences, University of Siena, 53100 Siena, Italy
2
Department Materno Infantile e Scienze Urologiche, University Sapienza, 00185 Rome, Italy
3
Chemistry Department, Sapienza University, 00185 Rome, Italy
*
Author to whom correspondence should be addressed.
Proteomes 2025, 13(4), 65; https://doi.org/10.3390/proteomes13040065
Submission received: 24 October 2025 / Revised: 27 November 2025 / Accepted: 5 December 2025 / Published: 10 December 2025
(This article belongs to the Section Identification of Potential Biomarkers and Potential Therapeutic Targets)
Browse Figures
Versions Notes

Abstract

Background: Non-muscle invasive bladder cancer (NMIBC) comprises high-grade (HG) and low-grade (LG) variants, classified by aggressiveness, recurrence risk, and stage—either non-invasive (pTa) or invading the lamina propria (pT1). Cystoscopy remains the diagnostic gold standard, with no less-invasive alternatives, while molecular mechanisms driving tumorigenesis and treatment response are poorly understood. Methods: To address this gap, we conducted a preliminary top-down proteomic study on fresh biopsies from pTa-LG and pT1-HG NMIBC at initial diagnosis to identify molecular differences and potential prognostic biomarkers. Results: Distinct protein profiles were observed between stages. Highly abundant proteins in pT1-HG were associated with nitric oxide biosynthesis, signal transduction, inhibition of apoptosis, protein folding, and immune response. Proteins of low abundance were related to cellular localization, cytoskeleton organization, cell adhesion, phagocytosis, and tissue development. Notably, multiple proteoforms of PDC6I/ALIX, a protein implicated in the regulation of apoptosis, proliferation, and PD-L1 surface presentation, were significantly downregulated in pT1-HG tumors. Furthermore, the abundance of proteins such as GANAB, GALE, THIC, SEPT8, and MYDGF/C19orf10 correlated with tumor size, suggesting their potential as prognostic biomarkers. Conclusions: These proteins, taken together, indicate that they may serve as valuable prognostic markers, offering a path toward more personalized management of NMIBC beyond the traditional one-size-fits-all approach.
Keywords: NMIBC; pTa-LG; pT1-HG; proteomics; prognostic markers; PDC6I/ALIX; 14-3-3ε; SOD2 NMIBC; pTa-LG; pT1-HG; proteomics; prognostic markers; PDC6I/ALIX; 14-3-3ε; SOD2

Share and Cite

MDPI and ACS Style

Vantaggiato, L.; Frisenda, M.; Shaba, E.; Splendore, C.; Sciarra, B.; Bini, L.; Sciarra, A.; Landi, C. Proteomic Profiling of Non-Muscle Invasive Bladder Cancer Reveals Stage-Specific Molecular Signatures and Prognostic Biomarkers. Proteomes 2025, 13, 65. https://doi.org/10.3390/proteomes13040065

AMA Style

Vantaggiato L, Frisenda M, Shaba E, Splendore C, Sciarra B, Bini L, Sciarra A, Landi C. Proteomic Profiling of Non-Muscle Invasive Bladder Cancer Reveals Stage-Specific Molecular Signatures and Prognostic Biomarkers. Proteomes. 2025; 13(4):65. https://doi.org/10.3390/proteomes13040065

Chicago/Turabian Style

Vantaggiato, Lorenza, Marco Frisenda, Enxhi Shaba, Chiara Splendore, Beatrice Sciarra, Luca Bini, Alessandro Sciarra, and Claudia Landi. 2025. "Proteomic Profiling of Non-Muscle Invasive Bladder Cancer Reveals Stage-Specific Molecular Signatures and Prognostic Biomarkers" Proteomes 13, no. 4: 65. https://doi.org/10.3390/proteomes13040065

APA Style

Vantaggiato, L., Frisenda, M., Shaba, E., Splendore, C., Sciarra, B., Bini, L., Sciarra, A., & Landi, C. (2025). Proteomic Profiling of Non-Muscle Invasive Bladder Cancer Reveals Stage-Specific Molecular Signatures and Prognostic Biomarkers. Proteomes, 13(4), 65. https://doi.org/10.3390/proteomes13040065

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop